聚糖
伤口愈合
化学
糖基化
生物化学
重编程
成纤维细胞
多糖
糖复合物
结构母题
细胞生物学
角质形成细胞
体内
合成致死
糖苷水解酶
炎症
体外
分泌物
细胞生长
RGD基序
真皮成纤维细胞
生物发生
细胞培养
细胞
巨噬细胞
中国仓鼠卵巢细胞
生物
作者
Yi-Xiang Wang,Yang Ruan,Na Zhao,Sixu Lu,Rui Ge,Jing Ling,C. L. Wells,Wenbin Shen,Gui‐Zhong Xin,Chaofeng Zhang,Lian‐Wen Qi,Xin‐Shan Ye,X Y Qin
摘要
Polysaccharides derived from Angelica dahurica exhibit potent wound healing activity, yet the pronounced structural heterogeneity of natural extracts has obscured the identity of the active motif and hindered clinical translation. Here we report a convergent, one-pot [22+22+22] glycosylation strategy based on glycosyl donor preactivation that enables the precise chemical synthesis of a 66-unit A. dahurica polysaccharide. This approach facilitates the efficient assembly of a comprehensive glycan library spanning tetrasaccharides to the full-length 66-mer polysaccharide, allowing for systematic biological evaluation. Functional screening identifies the reducing end hexasaccharide as the minimal active motif responsible for wound healing activity. Mechanistic analyses reveal that the synthetic hexa- and dodecasaccharides promote fibroblast and keratinocyte proliferation and migration, while concurrently reprogramming macrophage polarization. Crucially, gram-scale synthesis of both glycans enables definitive in vivo evaluation, demonstrating significantly accelerated wound closure through attenuation of excessive inflammation and promotion of organized collagen deposition. Collectively, these findings establish a general paradigm for deconvoluting heterogeneous natural polysaccharide extracts through de novo synthesis of structurally well-defined glycans as precision-engineered wound healing therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI